PHASE-II TRIAL OF DIDOX IN ADVANCED BREAST-CANCER

被引：33
|
作者：
RUBENS, RD
KAYE, SB
SOUKOP, M
WILLIAMS, CJ
BRAMPTON, MH
HARRIS, AL
机构：
[1] WESTERN INFIRM & ASSOCIATED HOSP,BEATSON ONCOL CTR,W SCOTLAND CLIN TRIALS UNIT,GLASGOW G12 0NY,SCOTLAND
[2] GLASGOW ROYAL INFIRM,GLASGOW G4 0FF,SCOTLAND
[3] SOUTHAMPTON GEN HOSP,CANC RES CAMPAIGN,MED ONCOL UNIT,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND
[4] CHARING CROSS HOSP,DEPT MED ONCOL,CANC RES CAMPAIGN,CTR PHASE 1-2 DATA,LONDON W6 8RF,ENGLAND
[5] CHURCHILL HOSP,IMPERIAL CANC RES FUND,DEPT CLIN ONCOL,OXFORD OX3 7LJ,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1991年 / 64卷 / 06期
关键词：
D O I：
10.1038/bjc.1991.488
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Fourteen patients with advanced breast cancer were treated with the ribonucleotide reductase inhibitor didox 6 g m-2 given by intravenous infusion over 36 h every 3 weeks. None responded and toxicity was minimal. Possibilities for the more effective use of this agent are discussed.
引用
收藏
页码：1187 / 1188
页数：2
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF TAMOXIFEN IN ADVANCED BREAST-CANCER
    WIGGANS, RG
    WOOLLEY, PV
    SMYTHE, T
    HOTH, D
    MACDONALD, JS
    GREEN, L
    SCHEIN, PS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 3 (01) : 45 - 48
  • [2] ADVANCED BREAST-CANCER - A PHASE-II TRIAL WITH GEMCITABINE
    CARMICHAEL, J
    POSSINGER, K
    PHILLIP, P
    BEYKIRCH, M
    KERR, H
    WALLING, J
    HARRIS, AL
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) : 2731 - 2736
  • [3] A PHASE-II TRIAL OF DANAZOL IN ADVANCED BREAST-CANCER
    PRONZATO, P
    MICHELOTTI, A
    AMOROSO, D
    ARDIZZONI, A
    LIONETTO, R
    CONTE, PF
    ROSSO, R
    ANTICANCER RESEARCH, 1986, 6 (03) : 362 - 362
  • [4] PHASE-II TRIAL OF SPIROGERMANIUM FOR TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, G
    FALKSON, HC
    CANCER TREATMENT REPORTS, 1983, 67 (02): : 189 - 190
  • [5] VINDESINE - A PHASE-II TRIAL IN ADVANCED BREAST-CANCER PATIENTS
    ROBINS, HI
    TORMEY, DC
    SKELLEY, MJ
    FALKSON, G
    CROWLEY, JJ
    RAMIREZ, G
    FALKSON, H
    CANCER CLINICAL TRIALS, 1981, 4 (04) : 371 - 375
  • [6] PHASE-II TRIAL OF ACIVICIN IN ADVANCED METASTATIC BREAST-CANCER
    FLEISHMAN, G
    YAP, HY
    MURPHY, WK
    BODEY, G
    CANCER TREATMENT REPORTS, 1983, 67 (09): : 843 - 844
  • [7] PHASE-II TRIAL OF PCNU IN REFRACTORY ADVANCED BREAST-CANCER
    KAVANAGH, JJ
    YAP, HY
    BLUMENSCHEIN, GR
    STEWART, D
    BODEY, GP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (03): : 249 - 251
  • [8] PHASE-II TRIAL WITH ORAL IDARUBICIN IN ADVANCED BREAST-CANCER
    LOPEZ, M
    DILAURO, L
    PAPALDO, P
    LAZZARO, B
    GANZINA, F
    DIPIETRO, N
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (01) : 39 - 42
  • [9] PHASE-II TRIAL OF VINDESINE (DVA) IN ADVANCED BREAST-CANCER PATIENTS
    SKELLEY, M
    TORMEY, D
    ROBINS, HI
    FALKSON, G
    CROWLEY, J
    FALKSON, H
    ANSFIELD, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 172 - 172
  • [10] RANDOMIZED PHASE-II TRIAL OF IPROPLATIN AND CARBOPLATIN IN ADVANCED BREAST-CANCER
    VERMORKEN, JB
    GUNDERSEN, S
    CLAVEL, M
    SMYTH, JF
    DODION, P
    RENARD, J
    KAYE, SB
    ANNALS OF ONCOLOGY, 1993, 4 (04) : 303 - 306
12345